UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-07 | Future report Set alerts | |
| Q2 2022 | 2022-08-15 | -0.23 | -0.23 |
| Q1 2022 | 2022-05-16 | -0.21 | -0.21 |
| Q4 2021 | 2022-03-08 | -0.35 | -0.35 |
| Q3 2021 | 2021-11-09 | -0.15 | -0.15 |
| Q2 2021 | 2021-08-05 | -0.36 | -0.36 |
| Q1 2021 | 2021-05-06 | -0.41 | -0.41 |
| Q4 2020 | 2021-02-23 | -0.33 | -0.33 |
| Q3 2020 | 2020-11-05 | -0.33 | -0.33 |
| Q2 2020 | 2020-08-06 | -0.35 | -0.35 |
| 2016-06-15 | Reiterated Rating | BTIG Research | Buy | $26.00 |
| 2016-05-16 | Reiterated Rating | Piper Jaffray | Overweight | $25.00 |
| 2016-05-16 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $25.00 |
| 2016-05-15 | Reiterated Rating | BTIG Research | Buy | $26.00 |
| 2016-04-11 | Reiterated Rating | BTIG Research | Buy | $26.00 |
| 2016-04-11 | Reiterated Rating | Piper Jaffray | Buy | |
| 2016-03-24 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $17.00 |
| 2016-01-29 | Reiterated Rating | William Blair | Buy | |
| 2016-01-08 | Initiated Coverage | William Blair | Outperform | |
| 2015-12-31 | Reiterated Rating | Piper Jaffray | Buy | $25.00 |
| 2015-12-16 | Initiated Coverage | Piper Jaffray | Overweight | $25.00 |
| 2015-11-20 | Reiterated Rating | BTIG Research | Buy | |
| 2015-10-26 | Reiterated Rating | BTIG Research | Buy | $28.00 |
| 2015-08-25 | Upgrade | BTIG Research | Neutral to Buy | $28.00 |
| 2015-08-16 | Reiterated Rating | BTIG Research | Hold | |
| 2015-07-20 | Initiated Coverage | BTIG Research | Neutral |
| 2016-06-15 | Reiterated Rating | BTIG Research | Buy | $26.00 |
| 2016-05-16 | Reiterated Rating | Piper Jaffray | Overweight | $25.00 |
| 2016-05-16 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $25.00 |
| 2016-05-15 | Reiterated Rating | BTIG Research | Buy | $26.00 |
| 2016-04-11 | Reiterated Rating | BTIG Research | Buy | $26.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In AXDX 0 funds of 2216 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| PATIENCE JOHN | 9.36% (4171211) | AXDX / SRCL / |
| SCHULER JACK W | 3.43% (1530423) | AXDX / BIOL / GTXI / HNSN / MBLX / MDT / QDEL / SRCL / VRML / |
| DDX INC /CO/ | 2.48% (1106793) | AXDX / |
| ARNOLD A ALEXANDER III | 1.78% (793000) | AXDX / |
| Mehren Lawrence CEO | 1.71% (762381) | AXDX / |
| FEINBERG LARRY N | 1.39% (621011) | AXDX / BIOL / HNSN / VRML / |
| GEIMER THOMAS J CEO/CFO | 0.76% (337985) | AXDX / |
| WILHELM DAVID C | 0.72% (319725) | AXDX / |
| Howson David President | 0.68% (301200) | AXDX / |
| GERRETSON CHARLES E | 0.31% (140150) | AXDX / |
| Strobeck Matthew | 0.31% (138235) | AXDX / MBLX / QDEL / |
| REICHLING STEVEN CFO | 0.07% (30700) | AXDX / |
| Kucera John D. | 0.06% (28663) | AXDX / |
| TEN BRINK FRANK JM | 0.02% (9800) | AXDX / SRCL / |
UM